Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | ALPL | P05186 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | ALPI | P09923 | 1/20 | 0.43 |
| ▸ | ALPG | P10696 | 1/20 | 0.43 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 3/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.42 |
| ▸ | MAOA | P21397 | 2/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL360271 | 0.90 | LMNA (0.52) | LMNAHPGDHIF1AHSD17B10PGAM1 | |
| SCHEMBL11179337 | 0.84 | LMNA (0.51) | LMNAHPGDHIF1AHSD17B10POLB | |
| SCHEMBL458284 | 0.83 | SMN1; SMN2 (0.48) | LMNAPGAM1POLBGAAALPL | |
| SCHEMBL8775893 | 0.83 | ALOX5 (0.57) | LMNAHPGDHIF1AHSD17B10POLB | |
| SCHEMBL28837581 | 0.81 | SMN1; SMN2 (0.46) | LMNAPGAM1POLBGAAALPL | |
| SCHEMBL19391945 | 0.79 | ALDH1A1 (0.53) | LMNAHPGDHSD17B10PGAM1POLB | |
| SCHEMBL7788575 | 0.79 | SMN1; SMN2 (0.50) | LMNAPGAM1POLBGAAL3MBTL1 | |
| SCHEMBL4889861 | 0.78 | HSD17B10 (0.48) | LMNAHPGDHIF1AHSD17B10ESR1 | |
| SCHEMBL890902 | 0.78 | ABL1 (0.48) | LMNAPGAM1GAAESR1ESR2 | |
| SCHEMBL16583502 | 0.78 | SMN1; SMN2 (0.50) | LMNAHSD17B10PGAM1L3MBTL1MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1073 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020068665-A1 | USE OF COLLAGEN BINDING DOMAINS TO DELIVER PRODUCTS TO SKIN | FABIUS BIOTECHNOLOGY (US) | 2020-04-02 | — | — | WO | claimed |
| US-20140127275-A1 | Composition Containing a Cellulose Derived Capsule With A Sunscreen | CoLabs International Corporation (US) | 2014-05-08 | — | — | US | claimed |
| EP-2367852-A1 | COSMETIC COMPOSITION CONTAINING ACETYLATED OLIGOGLUCURONANS | Sederma (FR) | 2011-09-28 | — | — | EP | claimed |
| US-20110008272-A1 | Use of Creatine or Creatine Compounds for Skin Preservation | AVICENA GROUP, INC. (US) | 2011-01-13 | — | — | US | claimed |
| WO-2010067327-A1 | COSMETIC COMPOSITION CONTAINING ACETYLATED OLIGOGLUCURONANS | SEDERMA (FR) | 2010-06-17 | — | — | WO | claimed |
| WO-2010044076-A2 | COSMETIC AND TOPICAL USE OF XANTHOHUMOL INCLUDING BRIGHTENING SKIN COMPLEXION AND REDUCING CUTANEOUS REDNESS | SEDERMA (FR) | 2010-04-22 | — | — | WO | claimed |
| US-20060193789-A1 | Surfacant, film forming agent, water, gas propellant; plant and animal extracts and oils; may include malathion | FOAMIX LTD. (IL) | 2006-08-31 | — | — | US | claimed |
| EP-1495103-A4 | TARGETED CONTROLLED DELIVERY COMPOSITIONS ACTIVATED BY CHANGES IN PH OR SALT CONCENTRATION | SALVONA LLC (US) | 2006-03-22 | — | — | EP | claimed |
| US-20050186158-A1 | Use of creatine or creatine compounds for skin preservation | AVICENA GROUP, INC. (US) | 2005-08-25 | — | — | US | claimed |
| US-6897281-B2 | Breathable polyurethanes, blends, and articles | NOVEON IP HOLDINGS CORP. (US) | 2005-05-24 | — | — | US | claimed |
| EP-1495103-A1 | TARGETED CONTROLLED DELIVERY COMPOSITIONS ACTIVATED BY CHANGES IN PH OR SALT CONCENTRATION | Salvona L.L.C. (US) | 2005-01-12 | — | — | EP | claimed |
| WO-2003087287-A1 | TARGETED CONTROLLED DELIVERY COMPOSITIONS ACTIVATED BY CHANGES IN PH OR SALT CONCENTRATION | SALVONA L.L.C. (US) | 2003-10-23 | — | — | WO | claimed |
| US-20030195133-A1 | Targeted controlled delivery compositions activated by changes in pH or salt concentration | SALVONA L.L.C. | 2003-10-16 | — | — | US | claimed |
| US-5837697-A | CONTAINING SALICYLIC ACID, SUNSCREEN AGENT AND A CARRIER | THE PROCTER & GAMBLE COMPANY (US) | 1998-11-17 | — | — | US | claimed |
| US-11957769-B2 | Polyhydroxy fullerene sunscreen active agents and compositions | THE CLEVELAND CLINIC FOUNDATION (US) | 2024-04-16 | — | — | US | disclosed |
| US-20240099948-A1 | Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents | COLABS INT'L CORP. (US) | 2024-03-28 | — | — | US | disclosed |
| EP-4329521-A2 | COLLAGEN COMPOSITIONS AND METHODS OF USE THEREOF | Modern Meadow, Inc. (US) | 2024-03-06 | — | — | EP | disclosed |
| US-4847069-A | SUNSCREEN AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1989-07-11 | — | — | US | disclosed |
| EP-0313305-A2 | Photoprotection compositions comprising chelating agents | THE PROCTER & GAMBLE COMPANY (US) | 1989-04-26 | — | — | EP | disclosed |
| US-4098881-A | COMPOSITIONS TO CONTROL THE CHRONIC EFFECTS OF EXPOSURE TO SUNLIGHT COMPRISING CONJUGATED DIENES | THE PROCTER & GAMBLE COMPANY (US) | 1978-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110008272-A1 | Use of Creatine or Creatine Compounds for Skin Preservation | PC, CKMT1A; CKMT1B, CHEK1 | LMNA 1116/4885HPGD 606/4885HIF1A 1913/4885 |
| US-20030195133-A1 | Targeted controlled delivery compositions activated by changes in pH or salt concentration | TRPC5, TRPV1, TRPV2 | LMNA 4180/4885HPGD 1445/4885HIF1A 423/4885 |
| US-20140127275-A1 | Composition Containing a Cellulose Derived Capsule With A Sunscreen | MSH6, TYR, CUTA | LMNA 3451/4885HPGD 1979/4885HIF1A 4292/4885 |
| US-20050186158-A1 | Use of creatine or creatine compounds for skin preservation | PC, CKMT1A; CKMT1B, CHEK1 | LMNA 1116/4885HPGD 606/4885HIF1A 1913/4885 |
| US-20240099948-A1 | Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents | MSN, LIPE, CUTA | LMNA 3449/4885HPGD 4237/4885HIF1A 4443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.